408 related articles for article (PubMed ID: 19458356)
1. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
Gutierrez A; Sanda T; Grebliunaite R; Carracedo A; Salmena L; Ahn Y; Dahlberg S; Neuberg D; Moreau LA; Winter SS; Larson R; Zhang J; Protopopov A; Chin L; Pandolfi PP; Silverman LB; Hunger SP; Sallan SE; Look AT
Blood; 2009 Jul; 114(3):647-50. PubMed ID: 19458356
[TBL] [Abstract][Full Text] [Related]
2. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.
Zuurbier L; Petricoin EF; Vuerhard MJ; Calvert V; Kooi C; Buijs-Gladdines JG; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Pieters R; Meijerink JP
Haematologica; 2012 Sep; 97(9):1405-13. PubMed ID: 22491738
[TBL] [Abstract][Full Text] [Related]
3. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
4. Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK-STAT signaling pathways.
Bonaccorso P; Bugarin C; Buracchi C; Fazio G; Biondi A; Lo Nigro L; Gaipa G
Cytometry B Clin Cytom; 2020 Nov; 98(6):491-503. PubMed ID: 32479694
[TBL] [Abstract][Full Text] [Related]
5. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability.
Silva A; Yunes JA; Cardoso BA; Martins LR; Jotta PY; Abecasis M; Nowill AE; Leslie NR; Cardoso AA; Barata JT
J Clin Invest; 2008 Nov; 118(11):3762-74. PubMed ID: 18830414
[TBL] [Abstract][Full Text] [Related]
6. PTEN/PI3K/Akt pathway alters sensitivity of T-cell acute lymphoblastic leukemia to L-asparaginase.
Hlozkova K; Hermanova I; Safrhansova L; Alquezar-Artieda N; Kuzilkova D; Vavrova A; Sperkova K; Zaliova M; Stary J; Trka J; Starkova J
Sci Rep; 2022 Mar; 12(1):4043. PubMed ID: 35260738
[TBL] [Abstract][Full Text] [Related]
7. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia.
Bentley VL; Veinotte CJ; Corkery DP; Pinder JB; LeBlanc MA; Bedard K; Weng AP; Berman JN; Dellaire G
Haematologica; 2015 Jan; 100(1):70-6. PubMed ID: 25281505
[TBL] [Abstract][Full Text] [Related]
8. Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.
Jotta PY; Ganazza MA; Silva A; Viana MB; da Silva MJ; Zambaldi LJ; Barata JT; Brandalise SR; Yunes JA
Leukemia; 2010 Jan; 24(1):239-42. PubMed ID: 19829307
[No Abstract] [Full Text] [Related]
9. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response.
Remke M; Pfister S; Kox C; Toedt G; Becker N; Benner A; Werft W; Breit S; Liu S; Engel F; Wittmann A; Zimmermann M; Stanulla M; Schrappe M; Ludwig WD; Bartram CR; Radlwimmer B; Muckenthaler MU; Lichter P; Kulozik AE
Blood; 2009 Jul; 114(5):1053-62. PubMed ID: 19406988
[TBL] [Abstract][Full Text] [Related]
10. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
11. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
[TBL] [Abstract][Full Text] [Related]
12. FAK mediates a compensatory survival signal parallel to PI3K-AKT in PTEN-null T-ALL cells.
You D; Xin J; Volk A; Wei W; Schmidt R; Scurti G; Nand S; Breuer EK; Kuo PC; Breslin P; Kini AR; Nishimura MI; Zeleznik-Le NJ; Zhang J
Cell Rep; 2015 Mar; 10(12):2055-68. PubMed ID: 25801032
[TBL] [Abstract][Full Text] [Related]
13. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
Li X; Zhang R; Liu Z; Li S; Xu H
Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
[TBL] [Abstract][Full Text] [Related]
14. NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia.
Guo D; Teng Q; Ji C
Leuk Lymphoma; 2011 Jul; 52(7):1200-10. PubMed ID: 21463127
[TBL] [Abstract][Full Text] [Related]
15.
Küçükcankurt F; Erbilgin Y; Fırtına S; Hatırnaz Ng Ö; Karakaş Z; Celkan T; Ünüvar A; Özbek U; Sayitoğlu M
Turk J Haematol; 2020 May; 37(2):98-103. PubMed ID: 31744268
[TBL] [Abstract][Full Text] [Related]
16. PTEN opposes negative selection and enables oncogenic transformation of pre-B cells.
Shojaee S; Chan LN; Buchner M; Cazzaniga V; Cosgun KN; Geng H; Qiu YH; von Minden MD; Ernst T; Hochhaus A; Cazzaniga G; Melnick A; Kornblau SM; Graeber TG; Wu H; Jumaa H; Müschen M
Nat Med; 2016 Apr; 22(4):379-87. PubMed ID: 26974310
[TBL] [Abstract][Full Text] [Related]
17. Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).
Hafsi S; Pezzino FM; Candido S; Ligresti G; Spandidos DA; Soua Z; McCubrey JA; Travali S; Libra M
Int J Oncol; 2012 Mar; 40(3):639-44. PubMed ID: 22200790
[TBL] [Abstract][Full Text] [Related]
18. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
[TBL] [Abstract][Full Text] [Related]
19. Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels.
Gomes AM; Soares MV; Ribeiro P; Caldas J; Póvoa V; Martins LR; Melão A; Serra-Caetano A; de Sousa AB; Lacerda JF; Barata JT
Haematologica; 2014 Jun; 99(6):1062-8. PubMed ID: 24561792
[TBL] [Abstract][Full Text] [Related]
20. Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibition.
Goltsov A; Faratian D; Langdon SP; Mullen P; Harrison DJ; Bown J
Cell Signal; 2012 Feb; 24(2):493-504. PubMed ID: 21996585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
